Rifampicin and CHC — DFSRH MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Advise switching to a method unaffected by enzyme induction, such as Cu-IUD, LNG-IUD or DMPA
Rifampicin is a potent enzyme inducer and can reduce CHC effectiveness, so a method unaffected by enzyme induction should be recommended. Patch use and dose doubling do not reliably overcome the interaction. Repeated UPA is not a planned contraception strategy and may also be affected by enzyme induction. The pearl is that long courses of enzyme-inducing drugs should trigger a planned method switch rather than repeated rescue care.
Reference: FSRH Drug Interactions with Hormonal Contraception; FSRH Guideline: Combined Hormonal Contraception